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Summary
Chartreusin is a potent antitumor agent with a mixed
polyketide-carbohydrate structure produced by Strep-
tomyces chartreusis. Three type II polyketide syn-
thase (PKS) gene clusters were identified from an
S. chartreusis HKI-249 genomic cosmid library, one
of which encodes chartreusin (cha) biosynthesis, as
confirmed by heterologous expression of the entire
cha gene cluster in Streptomyces albus. Molecular
analysis of the 37 kb locus and structure elucidation
of a linear pathway intermediate from an engineered
mutant reveal that the unusual bis-lactone aglycone
chartarin is derived from an anthracycline-type poly-
ketide. A revised biosynthetic model involving an oxi-
dative rearrangement is presented.
Introduction
Chartreusin (1, Figure 1) is an aromatic polyketide gly-
coside isolated from Streptomyces chartreusis that
consists of fucose, digitalose, and an unusual bislac-
tone aglycone, named chartarin [1, 2]. While chartreusin
was first investigated because of its antibacterial activ-
ity [1], further studies revealed a significant chemother-
apeutic activity against various tumor cell lines, such
as murine P388 and L1210 leukemia, and B16 mela-
noma cells [3]. Unfortunately, development of chartreu-
sin has been hampered by its unfavorable pharma-
cokinetics due to rapid biliary excretion and slow
gastrointestinal absorption [3].
Given the remarkably high antitumor activity in vitro,
there is considerable interest in addressing these phar-
macokinetic shortcomings by accessing natural and
semisynthetic chartreusin analogs with improved prop-
erties in vivo [4]. A natural derivative of 1, elsamicin A or
elsamitrucin (2, Figure 1), produced by an unidentified
actinomycete strain, has improved water solubility due
to the amino sugar moiety [5]. Both elsamicin A and a
semisynthetic derivative of chartreusin, IST-622 (Figure
1), which appears to be a pro-drug with more suitable
pharmacokinetic properties, have reached phase II clin-
ical trials [6]. Pharmacological studies revealed that*Correspondence: christian.hertweck@hki-jena.dechartreusin and its derivatives exert their antitumor
activities through binding to DNA [7], radical-mediated
single-strand breaks, and inhibition of topoisomerase II
[8]. Chartreusin and elsamicin A recognize almost the
same G+C-rich DNA sequences, and analogs modified
in the disaccharide portion of 1 retained antileukemic
effects in vivo [4]. Consequently, there is strong evi-
dence that the unusual polycyclic aromatic aglycone,
named chartarin (3), represents a key element for bio-
activity [9, 10].
Early 13C-labeling experiments clearly revealed that
the coumarin-related aglycone 3 of chartreusin and el-
samicin is derived entirely from acetate and is thus sup-
posedly of polyketide origin [11–13]. However, to date,
the exact biosynthetic pathway to chartarin has re-
mained unresolved, as the labeling pattern of acetate
precursors is atypical for a polyketide metabolite (Fig-
ure 1). It was suggested that two individual polyketide
chains are fused during the biosynthesis [14]; however,
in the currently accepted biosynthetic model, an un-
decaketide-derived benzopyrene intermediate, 11, is
believed to undergo a series of oxidative C-C bond
fissions and rearrangements [11, 12] (see below) remi-
niscent of the biosynthesis of gilvocarcin [15]. It should
be mentioned that the formation of chrymutasin (4) [16],
a metabolite of a randomly generated S. chartreusis
mutant, cannot be rationalized with the current model.
Here, we report on the cloning, sequencing, and het-
erologous expression of a gene cluster encoding char-
treusin biosynthesis to set the ground for genetically
engineering analogs with improved pharmacokinetic
properties. In addition, based on sequence analyses
and structural elucidation of a pathway intermediate
from a blocked mutant, we present a revised biosyn-
thetic model for chartreusin biosynthesis.
Results
Identification, Cloning, and Heterologous Expression
of the Chartreusin Biosynthetic Gene Cluster
Despite its highly unusual ring system, the aromatic
structure and the labeling pattern suggest the involve-
ment of an aromatic (type II) polyketide synthase in
chartreusin biosynthesis, as well as tailoring enzymes
that catalyze an unprecedented, to our knowledge, re-
arrangement of a yet unidentified polyphenolic precur-
sor. An S. chartreusis HKI-249 genomic cosmid library
was constructed by using the integrative shuttle cos-
mid vector pOJ436 [17]. The library consisting of 2324
clones was screened with a ketosynthase (KSα) probe
by dot blot/colony hybridization [18]. Nineteen positive
cosmids were subjected to restriction mapping and
Southern hybridization, revealing three individual loci.
For characterization of the three putative type II PKS
gene clusters (pks1–3), spot sequencing, heterologous
expression, and inactivation experiments were under-
taken. Heterologous expression of cosmid pSC6M16
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580Figure 1. Structures of the Potent Antitumor Agents Chartreusin,
Elsamicin, and IST-622, and Acetate Labeling Pattern of the Agly-
cone Charartinconferred on the host Streptomyces lividans ZX1 [19]
the ability to produce a blue-gray pigment, which is
also formed by S. chartreusis HKI-249 when grown on
R2YE plates. Thus, cluster pks1 might encode a spore
pigment biosynthetic pathway. Spot sequencing of
cosmid pSC2N16 and homology searches revealed that
cluster pks2 codes for the biosynthesis of an angucy-
cline-type metabolite. However, to date, all attempts to
express the cluster in a heterologous host have failed,
and genomic disruption by insertional mutation did not F
Sresult in an altered metabolic profile. Thus, it is likely
(that cluster pks2 is silent under standard cultivation
tmethods. All cosmids bearing cluster pks3, which
(strongly resembled an anthracycline-type gene cluster
cby spot sequencing, were introduced into S. lividans
ZX1 [19] and Streptomyces albus [20] by PEG-induced
protoplast transformation and intergenic conjugation,
w
respectively. While none of the S. lividans trans-
a
formants produced any chartreusin, the metabolite was
s
unequivocally detected by its characteristic blue fluo-
v
rescence on TLC plates in an extract of the transconju-
B
gant S. albus::pSC5P21. The identity of 1 produced
(
by the recombinant strain was further established by
8
HPLC/MS by using an authentic sample, as well as by
T
MSn analyses (Figure 2). Since cosmid pSC5P21 ap-
p
peared to contain all genes necessary to encode
a
chartreusin (cha) biosynthesis, the entire insert DNA
o
(w40 kb) was subjected to shotgun sequencing. All re-
c
maining gaps were filled by targeted subcloning and
S
primer walking, except for a probable terminator region
(<140 bp) between chaX and chaK, which could not be R
resolved by any means. The nucleotide (nt) sequence
T
was deposited at the EMBL database under the acces-
c
sion numbers AJ786382 and AJ786383.
p
c
gArchitecture of the Genomic Region Involved
in Chartreusin Biosynthesis S
tAnalysis of the sequence for open reading frames
(ORFs) with the FRAMEPlot program [21] and alignment rigure 2. Detection of Chartreusin in Wild-Type and Recombinant
trains
A) HPLC profiles of crude extracts from (a) wild-type S. char-
reusis, (b) S. albus/pSC5P21, and (c) host S. albus.
B and C) MSn analyses (in positive [B] and negative [C] modes) of
hartreusin (1) produced by S. albus/pSC5P21.ith related sequences in the database revealed the
rchitecture of the entire w37 kb chartreusin (cha) bio-
ynthesis gene cluster, which is flanked by genes in-
olved in primary metabolism and housekeeping.
ased on homology searches, 35 open reading frames
ORFs) that consist of 27 probable structural genes and
genes for regulation and resistance were detected.
he gene organization of the gene cluster is graphically
resented in Figure 3, and the results of the sequence
nalyses are summarized in Table 1. Putative functions
f deduced gene products were assigned by sequence
omparisons with database proteins (BLAST and PRO-
ITE searches [22]).
egulatory and Resistance Genes
hree probable regulatory genes were located on the
ha gene cluster. ORF chaR1 is similar to a variety of
athway-specific SARP regulator genes from other se-
ondary metabolite biosynthesis gene clusters, such as
rhR2 from Streptomyces sp. JP95 [23] and aknO from
treptomyces galilaeus [24]. A second protein with po-
ential regulatory function is encoded by chaR2 and
esembles several putative regulatory proteins from
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581Figure 3. Organization of the cha Biosynthesis Gene Cluster in S. chartreusis
Each arrow indicates the direction of transcription and the relative sizes of the ORFs deduced from analysis of the nucleotide sequence.
Black ORFs, minimal PKS and cyclase/aromatase genes; light-gray ORFs, ketoreductase genes; dark-gray ORFs, oxidoreductase and methyl
transferase genes; checked ORFs, probable regulatory and resistance genes; hatched ORFs, genes putatively involved in deoxysugar biosyn-
thesis and attachment; white ORFs, genes of unknown function.Streptomyces coelicolor [25] and Streptomyces aver-
mitilis [26], which all contain a pfam06036 motif. Pro-
teins of this family are thought to be involved in sporu-
lation. The deduced gene product of the third
candidate regulator gene (chaR3) resembles putative
LacI family transcriptional regulators, which have been
identified in the genomes of S. avermitilis [26] and
S. coelicolor [25].
Several genes, chaT1–5, that are probably involved
in export and self-resistance were identified in the right-
hand side of the cluster. The deduced protein of chaT1
shows a motif of sugar transporters (pfam00083.11), such
as the drug transporter of Mycobacterium tuberculosis
(accession no. CAA15906). Another closely related pro-
tein is a transmembrane efflux protein from S. avermitilis
[26]. The deduced gene products of ORFs chaT2–5,
which are clustered together, are similar to components
of ATP binding cassette (ABC) ion transporters from
Kineococcus radiotolerans (see Table 1). Based on se-
quence homologies, the gene product of chaT2 pre-
sumably functions in surface adhesion, and ChaT3 and
ChaT4 would represent the ATPase and permease
components, respectively. ChaT5 has the highest sim-
ilarity to an ion-transporting ATPase from S. coelicolor
(accession no. CAA22769). ABC transporters are known
to confer self-resistance to the polyether ionophore
tetronasin to Streptomyces longisporoflavus [27] and
have also been implicated in polyene macrolide resis-
tance [28].
Genes Encoding a Type II Polyketide Synthase
Bacterial type II (aromatic) PKSs are typically com-
posed of a single set of iteratively used individual pro-
teins. A β-ketoacyl synthase (KSα), a so-called chain
length factor (CLF, or KSβ), and an acyl carrier protein
(ACP), which acts as an anchor for the growing polyke-
tide chain, are responsible for the formation of the poly-
β-keto chains, and are thus referred to as a minimal
PKS. Three ORFs encoding the chartreusin minimal
PKS are located centrally in the cha gene cluster. All
deduced gene products are closely related to known
aromatic PKS components. However, the deduced
gene products of the two ketosynthase subunits, ChaA
and ChaB, are most similar to PKS involved in the bio-
synthesis of decaketides, such as tetracenomycin [29],
nogalamycin [30], and aklavinone [31], and not to PKSs
involved in making longer polyketide chains, as would
be predicted from the current biosynthetic scheme.
Other PKS Genes
The deduced gene products of chaD, chaE, and chaL
show a distinct dehydrogenase motif (pfam00106), andthe highest scores are with ketoreductases involved in
the processing of poly-β-keto intermediates. ChaD and
ChaE, which share 54.8% sequence identity, resemble
C-9 ketoreductases, such as AknA [31]. ChaL also be-
longs to the family of ketoreductases; however, it is
more related to C-17 ketoreductases, which are repre-
sented by AknU [32], DnrH [33], and SnoaF [34].
Candidate genes encoding cyclases and aromatases
that are involved in the directed folding of the nascent
polyketide chain are chaF, chaG, chaJ, and chaK. ChaF
is similar to a family of proteins that is known to cata-
lyze the dehydratation/aromatization of the A-ring of
anthracyclic polyketides, including AknE1, RdmK, and
SnoaE [30, 31]. The deduced 231 aa gene product of
chaG shows a conserved motif (HxGTHxDxPxH) that is
likely to form part of the active site of cyclases
(pfam04199.6). The closest relatives of ChaG are cy-
clases required for complete cyclization of the second
and, most probably, also the third ring of linear polyke-
tides [35], such as CmmY (chromomycin) [36], SnoaM
(nogalamycin) [34], and AknW (aclarubicin) [24].
Two genes, chaJ and chaK, probably encode two
copies of ester cyclases similar to the nogalonic acid
methyl ester transferase, SnoaL, and functionally iden-
tical cyclases, DnrD, RdmA, DauD, and AknH, from re-
lated anthracycline pathways [37]. These enzymes are
known to catalyze an aldol-type cyclization of the
fourth (D) ring [38].
Probable Post-PKS Genes
The deduced gene product of chaI resembles SAM-
dependent methyl transferases (COG0500.1) from se-
condary metabolite pathways. ChaI shows the highest
sequence identity to aklanonic acid methyl transfer-
ases (AknG) from the Streptomyces galilaeus aklavi-
none (69% identity) [31] and the Streptomyces peuce-
tius daunorubicin pathways (59% identity) [39], as well
as to the nogalonic acid methyl transferase SnoaC from
Streptomyces nogalater (56% identity) [40].
In the cha biosynthetic gene cluster, four putative ox-
ygenases are encoded that are putatively involved in
tailoring, disruption, and rearrangement of the aromatic
polyketide ring system of a chartarin precursor. The
deduced 106 aa gene product of chaH resembles
anthrone oxygenases (pfam03992.6). Related enzymes,
which probably occur as multimers, are involved in the
biosynthesis of aklavinone AknX (BAB72044.1) [31] and
nogalamycin SnoaB (CAA12015.1) [30]. These oxygen-
ases are responsible for the introduction of the quinone
oxygen at C-12 of aklanonic acid and nogalonic acid,
respectively. ChaX shares the highest similarity with pu-
tative hydroxylases AclQ (accession no. BAB72056,
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Deduced Sequence Similarity (Protein, Similarity/
Protein Size (aa) Proposed Function Origin) Identity, % Accession Number
ChaW 433 Unknown Nostoc sp. PCC 7120 46/29 NP_488388
ChaM 257 SAM-dependent methyl Ralstonia eutropha 54/39 ZP_00168466
transferase
ChaGT2 373 Glycosyl transferase Crocosphaera watsonii 61/45 ZP_00176915
ChaG 231 Cyclase (2nd + 3rd ring) CmmY, Streptomyces griseus 70/59 CAE17518
subsp. griseus
ChaF 318 Cyclase/Aromatase AknE1, Streptomyces galilaeus 68/56 BAB72042
ChaD 260 C-9 Keto reductase AknA, Streptomyces galilaeus 78/71 BAB72043
ChaN 145 Unknown SnoO, Streptomyces nogalater 51/41 AAF01807
ChaS3 163 NDP-4-Keto-6-deoxy-D- Thermobifida fusca 45/30 ZP_00293833
glucose reductase
ChaR1 216 SARP family regulator Orf71, Streptomyces rochei 72/58 NP_851493
ChaA 422 Ketoacyl synthase TcmK, Streptomyces glaucescens 75/66 P16538
ChaB 408 Chain length factor Snoa2, Streptomyces nogalater 71/62 CAA12018
ChaC 85 Acyl carrier protein NcnC, Streptomyces arenae 60/42 AAD20269
ChaGT1 381 Glycosyl transferase CloM, Streptomyces 53/39 AAN65229
roseochromogenes subsp.
oscitans
ChaS1 352 NDP-Hexose synthase LanG, Streptomyces cyanogenus 66/50 AAD13545
ChaS4 310 Nucleoside-diphosphate- SpcI, Streptomyces netropsis 48/37 AAD45554
sugar epimerase
ChaH 106 Anthrone oxygenase SnoaB, Streptomyces nogalater 62/51 CAA12015
ChaS2 332 NDP-D-Glucose 4,6- Corynebacterium glutamicum 69/56 BAB97727
dehydratase
ChaR2 437 Putative transcriptional Streptomyces avermitilis 36/20 NP_825027
regulator
ChaP 130 Dioxygenase Ralstonia eutropha 68/51 ZP_00166028
ChaU 137 Ester cyclase AclR, Streptomyces galilaeus 77/59 BAB72057
ChaX 287 Hydroxylase AclQ, Streptomyces galilaeus 60/55 BAB72056
ChaK 147 Ester cyclase RdmA, Streptomyces 77/67 AAA83420
purpurascens
ChaL 246 C-17 Keto reductase DauE, Streptomyces sp. C5 71/58 AAB08021
ChaE 261 C-9 Keto reductase AknA, Streptomyces galilaeus 71/59 BAB72043
ChaZ 395 FAD-dependent Photorhabdus luminescens subsp. 52/35 CAE14036
monooxygenase laumondii
ChaI 286 SAM-dependent methyl AknG, Streptomyces galilaeus 69/59 BAB72050
transferase
ChaJ 138 Ester cyclase DnrD, Streptomyces peucetius 75/59 AAA99000
ChaT1 542 Drug transporter Mycobacterium tuberculosis 50/34 NP_215766
transmembrane efflux
protein
ChaO 387 Isovaleryl-CoA Frankia sp. EuIK1 86/78 AAL02422
dehydrogenase
ChaQ 247 Hypothetical protein Streptomyces avermitilis 68/54 BAC70751
ChaT2 307 ABC-type metal ion transport Kineococcus radiotolerans 67/56 ZP_00227783
system
ChaT3 268 Mn/Zn transport systems, Kineococcus radiotolerans 71/56 ZP_00227784
ATPase component
ChaT4 288 ABC-type Mn2+/Zn2+ Kineococcus radiotolerans 86/72 ZP_00227785
transport systems,
permease components
ChaT5 686 Putative cation-transporting Streptomyces coelicolor A3(2) 77/69 CAA22769
ATPase
ChaR3 354 Putative LacI-family Streptomyces avermitilis 59/45 BAC68741
transcriptional regulator55% identity) from S. galilaeus and SnoaW (accession k
bno. AAF01810, 47% identity) from S. nogalater. The
function of these proposed monooxygenases has not f
mbeen established to date. A putative FAD-dependent
monooxygenase with a conserved C-terminal domain t
r(pfam01360.11) is encoded by chaZ. The probable 395
aa enzyme is related to an unnamed hypothetical pro- g
ttein from the entomopathogenic bacterium Photorhab-
dus luminescens (NP_929024.1), whose function is un- snown [41]. The deduced 130 aa gene product of chaP
elongs to the superfamily of vicinal oxygen chelate
old (VOC) oxidoreductases. It shows a conserved do-
ain (pfam00903.11) that is found in a variety of struc-
urally related metalloproteins, including the bleomycin
esistance protein, glyoxalase, and ring-cleaving dioxy-
enases. The closest relative of ChaP is a lactoylglu-
athione lyase from Ralstonia eutropha JMP134 (acces-
ion no. ZP_00166028.1, 51% identity).
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of Deoxyhexoses
Chartreusin contains two deoxysugars, D-fucose and
D-digitalose, that are attached to the chartarin agly-
cone. Several genes that are possibly involved in sugar
biosynthesis and attachment [42] have been detected
in the cha gene cluster. Activation of glucose 6-phos-
phate to the corresponding NDP-hexose is putatively
catalyzed by the deduced 352 aa gene product of
chaS1 (Figure 4), which is similar to a variety of NDP-
D-glucose synthases from Streptomycetes, e.g., LanG
(landomycin) from Streptomyces cyanogenus (acces-
sion no. AAD13545) and VinA (vicenistatin) from Strep-
tomyces halstedii (accession no. BAD08355). The de-
duced gene product of chaS2, which incorporates an
epimerase motif (pfam01370.11), seems to belong to
the NAD-dependent epimerase/dehydratase family of
enzymes. ChaS2 has the highest sequence identity to
a dTDP-D-glucose 4,6-dehydratase from Corynebacte-
rium glutamicum (accession no. BAB97727).
The subsequent conversion of NDP-4-keto-6-deoxy-
D-glucose to NDP-D-fucose is putatively catalyzed by
the deduced 163 aa gene product of chaS3, a probable
NDP-glucose-4-keto-6-deoxy-D-glucose reductase of
the GtrA family (pfam04138.6). Related membrane
bound proteins are known to take part in the biosynthe-
sis of NDP-D-fucose in the context of serotype-specific
polysaccharide antigen formation, as by Actinobacillus
actinomycetemcomitans Y4 [43]. Curiously, in the cha
gene cluster, a second candidate gene for a 4-epim-
erase can be found. ORF chaS4 codes for a protein
that shows a dehydrogenase motif (COG1028.1) at its
N terminus and an epimerase motif at its C terminus
(pfam01370.11). ChaS4 is most similar to several NAD-
dependent NDP-hexose-4-epimerases, such as SpcI
(spectinomycin) from Streptomyces netropsis (acces-
sion no. AAD45554, 37% identity), which is implicated
in the biosynthesis of the fucose-derived aminoglyco-
side spectinomycin.
ChaS1–4 would be sufficient for the biosynthesis of
NDP-D-fucose. For the synthesis of D-digitalose, which
is equivalent to 3-O-methylated fucose, an O-methyl
transferase is required, which is most likely encoded by
chaM. The deduced 257 aa sequence of ChaM clearlyFigure 4. Proposed Pathway for the Biosynthesis of the 6-Deoxysu-
gars in Chartreusinreveals an SAM-dependent methyl transferase motif
(COG0500.1) and shows 54% identity to a probable
SAM-dependent methyltransferase from Ralstonia eu-
tropha JMP134 (accession no. ZP_00168466).
Two genes in the cha cluster putatively encode glyco-
syltransferases. Upstream of chaS1 is a gene, chaGT1,
that codes for a glycosyl transferase (COG1819.1,
COG1819) with marked similarity to a variety of en-
zymes that catalyze the attachment of deoxyhexoses
to aromatic polyketide aglycones. Among the closest
relatives are the glycosyltransferases CmmGII (chro-
momycin) from Streptomyces griseus subsp. griseus
[36] (accession no. CAE17548, 39% identity) and NovM
(novobiocin) from Streptomyces spheroides [44] (ac-
cession no. AAF67506, 34% identity) as well as CouM
(coumermycin) from Streptomyces rishiriensis [45] (ac-
cession no. AAG29785, 38% identity), the latter of
which glycosylates coumarin-type aglycones.
The second glycosyltransferase required for the
transfer of the second sugar moiety (NDP-digitalose) is
putatively encoded by chaGT2. It should be pointed out
that ChaGT2 (pfam00535.11) shows only very low
similarity to glycosyl transferases from known second-
ary metabolite pathways. Its closest relative (45% iden-
tity) is a glycosyltransferases (accession no. ZP_
00176915.2) involved in cell wall biogenesis of Cro-
cosphaera watsonii WH 8501.
Genes of Unknown Function
ChaN is related to a family of proteins found in several
type II PKS pathways, including AknV (S. galilaeus) [24]
and SnoO (S. nogalater) [34]. Although it has been sug-
gested that these enzymes may participate in the gly-
cosylation of aclacinomycins, ChaN shows the con-
served motif (cd00667.2) of the β subunit of aryl ring
hydroxylating dioxygenases. However, only a structural
role has been attributed to this subunit. Interestingly,
ChaN is also similar to the C terminus of AknE1 from
S. galilaeus, a known cyclase-aromatase. ORF chaO
codes for a protein with very high similarity to an isoval-
eryl-CoA dehydrogenase from a Frankia sp. (accession
no. AAL02422, 78% identity). Its function in the context
of chartreusin biosynthesis remains unclear. ChaW and
ChaQ do not have any conserved motifs. They resem-
ble hypothetical proteins from Nostoc sp. PCC7120
(accession no. NP_488388) and S. avermitilis MA-4680
(accession no. NP_824216), respectively.
Inactivation of chaZ and Identification
of a Linear Polyketide
The deduced function of cha PKS gene products
strongly suggests that the biosynthesis of the polyke-
tide aglycone chartarin shares common steps with
anthracycline-type aromatic polyketides. Consequently,
the chartreusin and anthracyclin pathways would
branch at a specific biosynthetic step. We assumed
that the putative FAD-dependent oxygenase ChaZ
would play a crucial role in chartarin formation and
aimed at an inactivation of chaZ. This goal was
achieved by double crossover in E. coli by using the
λred system [46–48]. After excision of chaZ from the
cha gene cluster on cosmid pSC5P21 and confirmation
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cosmid (pXU-C01) was introduced into S. albus by in-
tergenic conjugation with E. coli [20]. Analysis of a plate
culture of the transconjugant S. albus::pXU-C01 re-
vealed that chartreusin production was fully abolished
in the mutant. Instead, an orange fluorescent metabo-
lite was produced. Isolation of this compound from the
extract of a medium-scale fermentation (10 l) by column
chromatography and preparative HPLC provided suffi-
cient material for full structural elucidation. From ESI
HR-MS and NMR data a molecular composition of
C21H14O6 was deduced. Except for aromatic proton sig-
nals, the 1H-NMR spectrum of 8 showed two chelated
hydroxyl protons at 13.73 and 12.21 ppm, as well as
one methyl and one methoxy group. The absence of
any methylene protons, as well as a H-H correlation and
coupling pattern accounted for a linear fully aromatic
polyketide. Database and literature searches revealed
that 8 is identical with resomycin C, an aromatic poly-
ketide that was only recently isolated in the Laatsch
group from Streptomyces sp. isolate GW71/2497 [49].
Strikingly, resomycin is only formed by the strain under
Fspecific cultivation methods, while it usually produces
c
large quantities of chartreusin.
T
t
Discussion p
Nature only provides a few different core polyketide
structures in aromatic polyketides by varying the chain w
length, position of the ketoreduction, and regiochemis- s
try of the cyclization events. All bacterial aromatic poly- t
ketide folds are either linear or angucyclic, except for c
resistomycin, which bears a unique discoid carbocyclic t
system [50]. The large structural diversity within the t
family of aromatic polyketides is rather dictated by the s
employment of different starter units [51], and by tai- l
loring enzymes [52], such as oxygenases, methylases, r
and glycosyl transferases. Oxidative rearrangement re- c
actions may result in entirely novel polyketide struc- b
tures. Dramatic examples are the enterocin [53] and a
griseorhodin [23] pathways, in which the rearrangement p
results in nonplanar polyketide ring systems. The pent- m
acyclic aromatic bislactone chartarin, which is relevant w
for the significant antitumor activities of chartreusin a
and elsamicin, represents another important example C
of a rearrangement of a regular polyketide, and the en- C
zymes involved in the elaboration of such unusual poly- a
ketide structures may provide new opportunities for U
combinatorial biosynthesis approaches. a
w
lChartreusin Shares Early Biosynthetic
Steps with Anthracyclines [
wThe current model for chartreusin biosynthesis involves
a benzopyrene precursor that is derived from an un- t
[decaketide (Figure 5). However, the high sequence sim-
ilarity of the ketosynthase subunits ChaA and ChaB a
cwith PKS enzymes from the tetracenomycin and nogal-
amycin pathways strongly suggested that chartarin is a
crather derived from a decaketide progenitor. We could
unequivocally prove this assumption by inactivation of r
man assumed key enzyme, ChaZ, as the resulting mutant
produces the anthracyclic polyketide 8 in lieu of r
cchartreusin. All deduced cha gene products are in lineigure 5. Revised Biosynthetic Model for the Chartreusin Agly-
one, Chartarin
he linear polyketide metabolite resomycin C (8) was isolated from
he chaZ null mutant. The previously proposed pathway via benzo-
yrene 11 is shown for comparison.ith this finding (Figure 5). The decaketide would be
ubject to ketoreduction at C-13, catalyzed by one of
he two C-9 ketoreductase candidates that are en-
oded by chaD and chaE, respectively. The ketoreduc-
ion most likely occurs on the A-ring after 7/12 cycliza-
ion, which is probably catalyzed by the ketoacyl
ynthase. Aromatization of the A-ring would be cata-
yzed by the putative aromatase ChaF, which strongly
esembles AknE1, RdmK, and SnoaE from anthracy-
line pathways [30]. Formation of the linear polyketide
ackbone is then promoted by ChaG. Similar cyclases
re involved in the cyclization of the second and, most
robably, also the third ring of chromomycin, nogala-
ycin, and aclarubicin [30, 36, 54]. The next steps
ould involve the oxidation of the proposed nogalic
cid intermediate by the putative anthrone oxygenase
haH [31], and methylation of the carboxyl group by
haI, which is strongly related to the SAM-dependent
klanonic acid and nogalonic acid methyl transferases.
pon methylation, the fourth ring would be formed by
n aldol-type cyclization catalyzed by ChaJ or ChaK,
hich both have similarity to ester cyclases from re-
ated anthracycline pathways, such as SnoaL and AknH
37, 38]. Finally, the putative C-17 ketoreductase ChaL
ould reduce the keto group, a reaction analogous to
hose catalyzed by AknU [55], DnrH [56], and SnoaF
54], yielding the anthracyclic aglycone of nogalamycin,
uramycinone (7). The deduced gene products of
haA-L would be sufficient for the biosynthesis of an
nthracyclin-type polyketide, such as 7. Compound 8
ould be derived from 7 by dehydration. However, it
emains unclear which enzymes are involved in the aro-
atization of the D-ring. Interestingly, 8 is identical to a
ecently identified metabolite, resomycin C, of another
hartreusin producer [49]. Since resomycin C is only
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585formed when the strain is cultivated under specific con-
ditions, it seems that, under these conditions, ChaZ is
produced at lower titers. With the finding that chartreu-
sin is derived from an anthracyclin, the current biosyn-
thetic model for 1 needed to be revised.
New Model for the Biosynthesis of Chartarin via
Rearrangement of an Anthracyclic Decaketide
Undoubtedly, the gene product of chaZ plays a crucial
role in the rearrangement of a linear polyketide interme-
diate, since deletion of chaZ results in the accumulation
of 8 and prevents any substrates from being made for
downstream reactions. The incorporation pattern sug-
gests that the first ring cleavage could occur adjacent
to the anthraquinone carbonyl of 8 (Figure 5). The puta-
tive FAD-dependent monooxygenase ChaZ could cleave
this carbon-carbon bond in a Baeyer-Villiger-type oxy-
genation. According to the labeling pattern, a new C-C
bond would be formed between the carbonyl and the
unsubstituted carbon of the C ring. Depending on the
nature of R, the ring fusion would occur by formylation
or acylation. A hydroxyl group could be introduced
either during the ring cleavage or by hydroxylation of
the angucyclic intermediate by the putative hydrox-
ylase ChaX, but the timing of hydroxylation cannot be
predicted as yet. Unfortunately, biotransformation ex-
periments with resomycin C by using a chaABC null
mutant have been unsuccessful to date. Thus, at this
stage, it cannot be ruled out that resomycin C (8) rather
represents a shunt product, while 6 or 7 are the true
substrates of ChaZ. In this case, aromatization of ring
D would take place later in the biosynthetic pathway.
However, once the framework of 9 has been estab-
lished, the quinone oxygen, probably in the enol form,
could attack the methyl ester carbonyl with substitution
of methanol and form the first lactone ring. The pro-
posed intermediate, 10, that results from this intramo-
lecular ring closure could be the substrate of another
unprecedented rearrangement reaction. The best can-
didate for such a reaction is the putative dioxygenase
ChaP. The rather small enzyme belongs to the vicinal
oxygen chelate (VOC) superfamily of enzymes. Metallo-
enzymes of this type are known to catalyze a variety of
reactions, including isomerizations (glyoxalase I), nucleo-
philic substitutions (fosfomycin resistance), and oxida-
tive cleavage of C-C bonds [57]. The latter comprise
the structurally and mechanistically fascinating extra-
diol dioxygenases, 4-hydroxyphenylpyruvate dioxygen-
ase, 2,3-dihydroxybiphenyl dioxygenase, and related
meta-cleavage dioxygenases [58]. In a similar fashion,
ChaP might disrupt the dione moiety of 10 by attack of
a dioxygen species and loss of carbon dioxide. Subse-
quent lactone formation would ultimately furnish the
chartarin aglycone. Elucidation of all pathway interme-
diates as well as mechanistic studies are in progress in
order to gain a deeper insight into this intriguing re-
arrangement cascade.
Molecular Basis for an Unusual Polyketide
Glycosylation Pattern
Besides the rearranged chartarin ring system, another
remarkable feature of chartreusin is the unusual 2-gly-
cosylation pattern of the fucose moiety. In the chacluster, all genes required for the biosynthesis of the
activated 6-deoxysugars NDP-D-fucose and NDP-D-
digitalose can be detected (chaS1–S4 and chaM, Fig-
ure 4). ChaGT1 is highly similar to a variety of glyco-
syltransferases involved in glycosylation of polyketide
aglycones, and it is thus considered to catalyze the at-
tachment of fucose to chartarin. The second glyco-
syltransferase required for the transfer of the second
sugar moiety (NDP-digitalose) is putatively encoded by
chaGT2. Since this enzyme would represent a 2-glyco-
syl transferase, which is unprecedented in secondary
metabolism, ChaGT2 unsurprisingly shows only very
low sequence similarity to glycosyl transferases from
known secondary metabolite pathways. It is more
closely related to glycosyltransferases involved in poly-
saccharide and cell wall biogenesis, where 1,2-glyco-
sidic linkages are more common. The enzymes in-
volved in the glycosylation of chartarin would be the
preferred targets for engineering chartreusin analogs
with improved solubility.
In conclusion, we have identified the chartreusin bio-
synthesis gene cluster out of three type II PKS gene
clusters from the genome of S. chartreusis HKI-249.
The cha cluster has been fully sequenced, and its iden-
tity was confirmed by heterologous expression. All
genes relevant for polyketide and sugar biosynthesis
have been assigned. Sequence comparisons and
knock-out of a key pathway enzyme, ChaZ, provide the
strongest evidence that chartreusin is derived from an
anthracyclic precursor. On the basis of this information
and on earlier isotope labeling results, a revised biosyn-
thetic model involving an unprecedented, to our knowl-
edge, rearrangement of an anthracyclic ring system is
proposed. Our work sets the basis for engineering
chartreusin analogs with improved pharmacological
properties and studying the enzymology of the intrigu-
ing tailoring reactions. These experiments are currently
underway in our laboratory.
Significance
The polyketide glycoside chartreusin (cha) produced
by Streptomyces chartreusis is a very potent antitu-
mor agent in vitro. Its development as a drug, how-
ever, is limited by its unfavorable pharmacokinetics
due to its low solubility. Cloning, sequencing, and
heterologous expression of the entire cha biosynthe-
sis gene cluster now sets the basis for rationally engi-
neering analogs with improved solubility.
Furthermore, the polyketide aglycone chartarin,
which is relevant for antitumor activity, has a unique
pentacyclic bis-lactone structure. Analysis of the cha
gene cluster and isolation of resomycin C from a ra-
tionally designed mutant proved that chartarin is
derived from an anthracyclic progenitor by an oxida-
tive rearrangement sequence. A revised biosynthe-
tic model rationalizing the irregular acetate-labeling
pattern of chartreusin is presented. Considering that
only relatively few polyketide ring systems are real-
ized in nature, the chartreusin pathway represents an-
other important example of the elaboration of unusual
cyclization patterns. Thus, the cha tailoring enzymes,
including unusual ring-cleaving oxidoreductases and
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586Fa putative 2-glycosyl transferase, are not only intrigu-
Cing from a mechanistic point of view, but are also
ppromising candidates for combinatorial biosynthetic
s
approaches. M
w
pExperimental Procedures
t
cBacterial Strains and Culture Conditions
0The chartreusin producer Streptomyces chartreusis HKI-249, ob-
mtained from the HKI strain collection, was used as the source of
(DNA in the construction of the genomic DNA library. S. lividans ZX1
c[19], kindly provided by Prof. Zhou, and S. albus [19], kindly pro-
(vided by Prof. Salas, served as host strains for heterologous ex-
pression experiments. For chartreusin production, wild-type and
2mutant strains were cultivated in MS medium (mannitol soya flour
nmedium) for 5 days at 28°C with shaking. S. lividans ZX1 was cul-
atured on R5 agar and YEME liquid medium [20] for protoplast
atransformation and on MS (mannitol soya flour) [23] for all other
rexperiments. Transformants were selected with apramycin or spec-
ptinomycin (Sigma) at 50 µg/ml in both solid and liquid medium.
E. coli strains DH5α and XL1 blue served as hosts for library con-
4struction and routine subcloning, respectively [59]. For intergenic
7conjugation, E. coli ET12567 containing the RP4 derivative
HpUZ8002 was used [20]. E. coli strains were grown in LB medium
(supplemented with ampicillin (100 µg/ml), or with apramycin (50
2µg/ml) for selection of plasmids [59].
(
(
tPlasmids and General DNA Procedures
DNA isolation, plasmid preparation, restriction digests, gel electro-
phoresis, and ligation reactions were conducted according to stan- A
dard methods [20, 59]. pBluescript II SK(-) [60] was the routine
vector for subcloning and preparation of DNA templates for se- T
quencing. The integrative E. coli-Streptomyces shuttle vector F
pOJ436 [17] was used for all expression experiments in Streptomy- w
ces. Restriction enzyme-digested DNA fragments were recovered c
from agarose gel by the GFX PCR DNA and Gel Band Purification s
Kit (Amersham). For Southern blot hybridization, the DIG DNA La- C
beling and Detection Kit (Roche) was used. Sequencing of l
pSC5P21 was performed with a shotgun approach. Remaining U
gaps were filled by targeted subcloning and primer walking. o
RConstruction and Screening of an S. chartreusis
RHKI-249 Genomic Cosmid Library
AAn S. chartreusis HKI-249 genomic cosmid library was constructed
Pin E. coli DH5α by using pOJ436 as a cosmid vector [17]. For DNA
extraction, mycelium was embedded in agarose, then the DNA was
Rpartially digested and isolated, yielding fragments with an average
size greater than 35 kb. Robotically produced high-density colony
arrays (Hybond N+; Amersham Pharmacia) were utilized for the
screening of 2304 cosmid clones with a strain-specific Type II PKS
probe by following standard hybridization procedures.
Inactivation of chaZ
The chaZ null mutant was constructed by using the λred system
[46–48]. To amplify the extended streptomycin and spectinomycin
resistance gene (aadA) flanked by FRT sites (FLP recognition targets)
and 39 nt from sense/antisense strands ending in start/stop co-
dons, two long primers, chaZ-P.T.L: 5#-TCGCCGCGCCGCCGAACA
GTGGGGAGGCGGGGGCCGATGATTCCGGGGATCCGTCGACC-3#
(59 nt), and chaZ-P.T.R: 5#-GAGGGCGTCCGCTGTCGAGTGGGTT
CCGTGTGCCGGTCATGTAGGCTGGAGCTGCTTC-3# (58 nt), were
designed. The PCR product was introduced into E. coli BW25113/
pIJ790 containing cosmid pSC5P21 with concomitant substitution
of the chaZ gene by the extended antibiotic resistance cassette.
The inserted cassette was removed through expression of the FLP-
recombinase in E. coli, yielding a 81 bp “scar” in the preferred read-
ing frame. The resulting plasmid, pXU-C01, was then introduced
into S. albus by intergenic conjugation by using E. coli ET12567
containing the RP4 derivative pUZ8002. The transconjugant S. al-
bus::pXU-C01 was selected for its apramycin resistance.ermentation and Isolation of Metabolites
hartreusin was extracted with ethyl acetate from chopped agar
lates or from liquid culture broths of wild-type and recombinant
trains. Extracts were concentrated in vacuo and redissolved in
eOH. Chartreusin was identified by comparison of the extracts
ith an authentic sample by thin-layer chromatography (TLC), high-
erformance liquid chromatography (HPLC), and mass spectrome-
ry (MS). HPLC analysis was carried out on a GROM-Sil ODS 0 AB
olumn (3 µm particle size, 250 × 4.6 mm) by using an acetonitrile/
.1% TFA gradient (0.5%–100% in 30 min) at a flow rate of 1.0 ml/
in and UV detection at 200–800 nm (max plot). Fragmentation
CID-MSn) of pseudomolecular ions ([M+Na]+) was conducted by
ollision-induced dissociation by using helium as the collision gas
Spray voltage: 5 kV, capillary temperature: 200°C.
For medium-scale fermentation, S. albus::pXU-C01 was grown in
0 liter baffled Erlenmeyer flasks, each containing 500 ml MS (man-
itol soya flour) medium supplemented with 50 µg/ml apramycin,
t 28°C in a rotary shaker. The culture was harvested after 6 days
nd was extracted with ethyl acetate. The crude extract was sepa-
ated on silica, and fractions containing 8 were further purified by
reparative HPLC. Spectroscopic data for 8:
1H-NMR (300 MHz, CDCl3): δ 13.73 (s, 1H, 6-OH), 12.21 (s, 1H,
-OH), 8.49 (d, J = 8.6 Hz, 1H, 7-H), 8.25 (s, 1H, 11-H), 7.88 (dd, J =
.5, 1.1 Hz, 1H, 1-H), 7.68 (“t,” J = 7.7 Hz, 1H, 2-H), 7.53 (d, J = 8.6
z, 1H, 8-H), 7.29 (dd, J = 7.7, 1.1 Hz, 1H, 3-H), 4.09 (s, 3H, OCH3),
3.69, 3.47,) 2.55 (s, 3H, 9-CH3) ppm. IR (crystal powder) ν 2956,
916, 1727, 1492, 1378, 1262, 1136, 1028 cm−1. ESI-MS (m/z): 747.6
2x M+Na)+ (100), 363.5 (M+H)+ (12). HRMS calcd. for C21H14O6
M+H): 363.0869, observed: 363.0858. 8 is in all respects identical
o the previously described resomycin C [49].
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